tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 246 are a BUY (97.23%), 7 are a HOLD (2.77%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 22.94% that have a potential upside of 43.09% achieved within 147 days.
Geulah Livshits’s has documented 440 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals at 27-Mar-2026.
Analyst best performing recommendations are on IMNM (IMMUNOME ).
The best stock recommendation documented was for IMNM (IMMUNOME ) at 8/20/2021. The price target of $21 was fulfilled within 25 days with a profit of $8.5 (68%) receiving and performance score of 27.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Sep-2018
$110
$64.25 (140.44%)
$105
13 days ago
(17-Mar-2026)
27/33 (81.82%)
$59.91 (119.60%)
235
Buy Since 28-Oct-2019
$76
$30.25 (66.12%)
$74
1 months 13 days ago
(17-Feb-2026)
2/16 (12.5%)
$22.83 (42.94%)
24
Hold Since 12-Feb-2025
$45
$-0.75 (-1.64%)
$40
1 months 17 days ago
(13-Feb-2026)
1/7 (14.29%)
$-8.07 (-15.21%)
47
Buy Since 16-Feb-2022
$82
$36.25 (79.23%)
$80
1 months 17 days ago
(13-Feb-2026)
8/27 (29.63%)
$28.93 (54.51%)
214
Buy Since 14-Feb-2025
$74
$28.25 (61.75%)
$99
1 months 17 days ago
(13-Feb-2026)
2/5 (40%)
$20.93 (39.44%)
22
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
